Sharp decline in US opioid overdose fatalities under Biden administration

TL/DR –

The Biden administration saw a rapid decline in opioid overdose fatalities in the US, a trend which experts suggest could be either continued or threatened by a second Trump administration. Overdose deaths declined for the first time in five years in 2023 and have continued to decrease since then. Despite the Trump administration’s previous efforts to combat the crisis, including the formation of the Presidential Commission on Combating Drug Addiction and the Opioid Crisis, the number of overdose deaths rose for most of Trump’s first term.

US Opioid Overdose Fatalities: A Decline under Biden Administration

Under the Biden administration, US opioid overdose fatalities have seen a rapid decline, marking the fastest decrease in decades. However, experts warn that a potential second Trump administration could either sustain or threaten this progress.

A Decrease in Overdose Deaths

For the first time in five years, 2023 saw a decrease in overdose deaths in the US, a trend that has continued to decline at an accelerated rate this year, according to provisional data. Much of this decline is attributed to Biden administration’s efforts to increase access to harm-reduction services.

Opioid Crisis: A Complex Legacy

The complex legacy of US presidents on the opioid crisis is notable. Opioid deaths more than doubled during the Obama administration and surged by 62% during Trump’s first term. Under Biden, they increased by 19% from 2020 to 2022, before decreasing by 2% last year.

Trump Administration’s Strategy and Future Outlook

Despite efforts like establishing the Presidential Commission on Combating Drug Addiction and expanding access to naloxone, the number of US overdose deaths climbed during much of Trump’s first term. Experts debate whether the administration’s focus on law and border enforcement over treatment exacerbated the crisis.

As Trump prepares for a potential second term, it’s challenging to predict how he’ll tackle the overdose crisis. Concerns arise over potential cuts to the Affordable Care Act and Medicaid, alongside a continued focus on drug arrests. Nonetheless, the Drug Policy Alliance remains committed to supporting any efforts towards increasing access to treatment and naloxone.

—
Read More Health & Wellness News ; US News